Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
about
The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment.Acute chest syndrome: sickle cell disease.Developing treatment for sickle cell disease.Cytokines in sickle cell disease.Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.Cerebral activation during von Frey filament stimulation in subjects with endothelin-1-induced mechanical hyperalgesia: a functional MRI studyNovel therapies targeting the endothelium in sickle cell disease.Sodium phenyl butyrate downregulates endothelin-1 expression in cultured human endothelial cells: relevance to sickle-cell disease.Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.Sickle erythrocytes increase prostacyclin and endothelin-1 production by cultured human endothelial cells under flow conditions.Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma.Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy.Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.Increased F2Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress
P2860
Q33607986-8FF48967-B4AE-43EB-B3BE-E19175372453Q34187526-989536FE-3C5A-4853-8936-392EE8B5F6A7Q34628666-9A6F7193-5481-4F76-A13F-D156648D38BDQ35552533-1B675152-CBF5-4DD3-BF67-043CE5D66C73Q35576474-89921E02-C54E-4760-867C-3F0E9D2D7CA8Q36088594-C5BD16AF-E6F0-4DB6-B277-E82C2B0D0F6EQ37159329-5E7A6518-3FC4-47A5-8C97-E086B1C00322Q37212250-F7F4DDDA-09EE-4C35-BFBA-660BCB1A8411Q37930655-45C003EB-AD63-4E31-990A-F1D6558E000EQ40156620-17976553-F4EE-44A1-8FFB-D3FE0FB89870Q40588101-62AFC389-CBAF-4B16-9C2C-C345C8BEE943Q43977840-F7470DD8-8421-444A-8549-1D3AC1BBBA64Q44030864-8A737405-7B81-4D71-901C-5E16EB52683FQ44355177-7F25A07F-F2BE-4448-B034-EE6720DC49AEQ45292131-77327235-CE4C-4CF9-AA02-3EEF6D90A6D1Q46321267-023F91BB-EF67-4E58-90B4-FD27AFB3BF3EQ46640340-1620B1BB-058D-4ECA-A334-EF9798BA2A34Q47271564-DFDFB077-C9CE-4E28-B45A-225D70D743E2Q58486006-CEA1FFA6-8683-4F45-840A-92C895F5B083
P2860
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
description
article
@en
im Juli 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1997
@uk
name
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@en
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@nl
type
label
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@en
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@nl
prefLabel
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@en
Endothelin-1 Production during the Acute Chest Syndrome in Sickle Cell Disease
@nl
P2093
P2860
P1476
Endothelin-1 production during the acute chest syndrome in sickle cell disease
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.156.1.9611085
P407
P577
1997-07-01T00:00:00Z